KNSA

Kiniksa Pharmaceuticals, Ltd.

Healthcare›Biotechnology|NASDAQ Global Select|BM

Price

$48.82

Market Cap

$3.62B

Beta

0.09

P/E

63.1

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+60.09%

EPS Growth (YoY)+223.97%

Revenue CAGR 3Y+45.45%

P/E Ratio63.1

PEG Ratio0.29

FCF Yield+3.77%

Debt / Equity0.02

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for KNSA.